Category Archives: News from Other Sources

AVI BioPharma is developing two new exon-skipping drugs; GlaxoSmithKline will conduct more trials of GSK2402968, for which participants are being recruited.

A drug approved in Europe to treat Lambert-Eaton myasthenic syndrome is now being tested in the United States; clinical trial participants sought.

ALS TDI’s 2011 Leadership Summit included the latest on ALS research and a discussion of speeding the pace of drug development.

Researchers at six centers are studying possible cardiac benefits of dietary supplement coenzyme Q10 and cardiovascular drug lisinopril in three MD forms.

CK-2017357 is being tested in combination with riluzole, and Neuralstem will test delivery of its stem cells into the cervical region of the spinal cord.

A multinational study supported by MDA and NINDS will study correlations between mutations and symptoms in four subtypes of Charcot-Marie-Tooth disease.

An MDA-supported open-label trial found the asthma drug benefited 17 of 18 people with either of two forms of congenital myasthenic syndrome.

Clinical trial testing experimental enzyme replacement drug in people with Pompe disease who are at least 13 years old.

New data show that Catena (idebenone) has a modest effect on respiratory function, bolstering results from an earlier trial.

Two separate trials will test the experimental drug CK-2017357 and a surgical procedure called a thymectomy in people with MG.